Growth in preterm infants until six months postterm: the role of insulin and IGF-I

Monique van de Lagemaat1, Joost Rotteveel, Annemieke C Heijboer

  • 1Pediatrics Department, VU University Medical Center, Amsterdam, The Netherlands.

Insights

Insulin-like growth factor type I (IGF-I) and insulin are key regulators of growth in preterm infants up to 6 months corrected age. These hormones influence growth independently of nutrient intake, highlighting their crucial role in early development.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Growth and Development
  • Metabolic Regulation

Background:

  • Term infants rely on IGF-I and insulin for growth.
  • Preterm infants require specific growth monitoring and support.
  • Understanding hormonal regulation is crucial for optimizing preterm infant outcomes.

Purpose of the Study:

  • To investigate the role of IGF-I and insulin in preterm infant growth.
  • To assess the relationship between these hormones and nutrient intake.
  • To determine growth patterns until 6 months corrected age (CA).

Main Methods:

  • Study included 138 preterm infants (gestational age 30.6 weeks).
  • Measurements of weight SDS, length SDS, IGF-I, and insulin were taken at term, 3, and 6 months CA.
  • Statistical analysis examined associations between hormones and growth parameters.

Main Results:

  • IGF-I and insulin levels at term and 3 months CA correlated with weight and length SDS.
  • These hormones were negatively associated with SDS gains between term and 6 months CA.
  • Nutrient intake did not show a significant association with IGF-I or insulin levels.

Conclusions:

  • IGF-I and insulin are significant growth regulators in preterm infants up to 6 months CA.
  • Their influence on growth appears independent of nutrient intake.
  • These findings underscore the importance of hormonal factors in preterm growth trajectories.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...